Tox21 Prepares to Launch Phase II of Chemical Screening Effort | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – A federal trans-agency initiative focused on using large-scale genomics, bioinformatics, and other technologies to predict how chemicals found in drugs, consumer, and industrial products, as well as food additives, will affect the human body and the environment has completed its first testing phases and now is moving on to begin screening a total of 10,000 chemicals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.